Targeted Prostate Biopsies Overestimate International Society of Urological Pathology Grade Group, Particularly in Smaller Tumors

In this report, we examined risk factors that could explain why some patients have higher pathological grading at prostate biopsy than on the whole prostate specimen after surgical removal. We found that patients with prostate biopsies that are targeted at small lesions on magnetic resonance imaging and patients who had high biopsy grading had a higher risk of having lower grading of their surgical specimens.

Authors

Institutions

Publication Details

Journal
European Urology Open Science
Published
2025-03-22
DOI
https://doi.org/10.1016/j.euros.2025.02.008
Citations
1
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeted Prostate Biopsies Overestimate International Society of Urological Pathology Grade Group, Particularly in Smaller Tumors

Lisa J Kroon, Monique J. Roobol, Charlotte F. Kweldam, Roderick C.N. van den Bergh et al.
1 citations
European Urology Open Science
Prostate Cancer Diagnosis and Treatment
1.52
article

Targeted Prostate Biopsies Overestimate International Society of Urological Pathology Grade Group, Particularly in Smaller Tumors

Lisa J Kroon, Monique J. Roobol, Charlotte F. Kweldam, Roderick C.N. van den Bergh, Ivo I. de Vos, Geert J.L.H. van Leenders
article en
1 citations

Abstract

In this report, we examined risk factors that could explain why some patients have higher pathological grading at prostate biopsy than on the whole prostate specimen after surgical removal. We found that patients with prostate biopsies that are targeted at small lesions on magnetic resonance imaging and patients who had high biopsy grading had a higher risk of having lower grading of their surgical specimens.

European Urology Open ScienceVol. 75
Maasstad Ziekenhuis (NL), Erasmus MC Cancer Institute (NL)
Jaap Schouten Foundation
Partnerships for the goals
Openalex Percentile: Top 21%
Prostate Cancer Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.